These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
206 related articles for article (PubMed ID: 9151831)
1. Characterization of human immunodeficiency virus type 1 matrix revertants: effects on virus assembly, Gag processing, and Env incorporation into virions. Ono A; Huang M; Freed EO J Virol; 1997 Jun; 71(6):4409-18. PubMed ID: 9151831 [TBL] [Abstract][Full Text] [Related]
2. Domains of the human immunodeficiency virus type 1 matrix and gp41 cytoplasmic tail required for envelope incorporation into virions. Freed EO; Martin MA J Virol; 1996 Jan; 70(1):341-51. PubMed ID: 8523546 [TBL] [Abstract][Full Text] [Related]
3. HIV-1 Matrix Trimerization-Impaired Mutants Are Rescued by Matrix Substitutions That Enhance Envelope Glycoprotein Incorporation. Tedbury PR; Novikova M; Alfadhli A; Hikichi Y; Kagiampakis I; KewalRamani VN; Barklis E; Freed EO J Virol; 2019 Dec; 94(1):. PubMed ID: 31619553 [TBL] [Abstract][Full Text] [Related]
4. Role of matrix in an early postentry step in the human immunodeficiency virus type 1 life cycle. Kiernan RE; Ono A; Englund G; Freed EO J Virol; 1998 May; 72(5):4116-26. PubMed ID: 9557701 [TBL] [Abstract][Full Text] [Related]
5. Mutational analysis of the conserved cysteine residues in the simian immunodeficiency virus matrix protein. González SA; Affranchino JL Virology; 1995 Jul; 210(2):501-7. PubMed ID: 7618287 [TBL] [Abstract][Full Text] [Related]
6. Virion incorporation of envelope glycoproteins with long but not short cytoplasmic tails is blocked by specific, single amino acid substitutions in the human immunodeficiency virus type 1 matrix. Freed EO; Martin MA J Virol; 1995 Mar; 69(3):1984-9. PubMed ID: 7853546 [TBL] [Abstract][Full Text] [Related]
7. Role of the matrix protein in the virion association of the human immunodeficiency virus type 1 envelope glycoprotein. Dorfman T; Mammano F; Haseltine WA; Göttlinger HG J Virol; 1994 Mar; 68(3):1689-96. PubMed ID: 8107229 [TBL] [Abstract][Full Text] [Related]
8. The matrix protein of human immunodeficiency virus type 1 is required for incorporation of viral envelope protein into mature virions. Yu X; Yuan X; Matsuda Z; Lee TH; Essex M J Virol; 1992 Aug; 66(8):4966-71. PubMed ID: 1629961 [TBL] [Abstract][Full Text] [Related]
9. Identification of domains in the simian immunodeficiency virus matrix protein essential for assembly and envelope glycoprotein incorporation. González SA; Burny A; Affranchino JL J Virol; 1996 Sep; 70(9):6384-9. PubMed ID: 8709267 [TBL] [Abstract][Full Text] [Related]
10. Role of the Gag matrix domain in targeting human immunodeficiency virus type 1 assembly. Ono A; Orenstein JM; Freed EO J Virol; 2000 Mar; 74(6):2855-66. PubMed ID: 10684302 [TBL] [Abstract][Full Text] [Related]
11. Role of the major homology region of human immunodeficiency virus type 1 in virion morphogenesis. Mammano F; Ohagen A; Höglund S; Göttlinger HG J Virol; 1994 Aug; 68(8):4927-36. PubMed ID: 8035491 [TBL] [Abstract][Full Text] [Related]
12. Tail-interacting protein TIP47 is a connector between Gag and Env and is required for Env incorporation into HIV-1 virions. Lopez-Vergès S; Camus G; Blot G; Beauvoir R; Benarous R; Berlioz-Torrent C Proc Natl Acad Sci U S A; 2006 Oct; 103(40):14947-52. PubMed ID: 17003132 [TBL] [Abstract][Full Text] [Related]
13. p6Gag is required for particle production from full-length human immunodeficiency virus type 1 molecular clones expressing protease. Huang M; Orenstein JM; Martin MA; Freed EO J Virol; 1995 Nov; 69(11):6810-8. PubMed ID: 7474093 [TBL] [Abstract][Full Text] [Related]
14. Reversion of a human immunodeficiency virus type 1 matrix mutation affecting Gag membrane binding, endogenous reverse transcriptase activity, and virus infectivity. Kiernan RE; Ono A; Freed EO J Virol; 1999 Jun; 73(6):4728-37. PubMed ID: 10233933 [TBL] [Abstract][Full Text] [Related]
15. Impact of natural polymorphism within the gp41 cytoplasmic tail of human immunodeficiency virus type 1 on the intracellular distribution of envelope glycoproteins and viral assembly. Lambelé M; Labrosse B; Roch E; Moreau A; Verrier B; Barin F; Roingeard P; Mammano F; Brand D J Virol; 2007 Jan; 81(1):125-40. PubMed ID: 17050592 [TBL] [Abstract][Full Text] [Related]
16. Mutations in the matrix protein of human immunodeficiency virus type 1 inhibit surface expression and virion incorporation of viral envelope glycoproteins in CD4+ T lymphocytes. Lee YM; Tang XB; Cimakasky LM; Hildreth JE; Yu XF J Virol; 1997 Feb; 71(2):1443-52. PubMed ID: 8995670 [TBL] [Abstract][Full Text] [Related]
17. Direct interaction between the envelope and matrix proteins of HIV-1. Cosson P EMBO J; 1996 Nov; 15(21):5783-8. PubMed ID: 8918455 [TBL] [Abstract][Full Text] [Related]
18. Positive and negative modulation of virus infectivity and envelope glycoprotein incorporation into virions by amino acid substitutions at the N terminus of the simian immunodeficiency virus matrix protein. Manrique JM; Celma CC; Hunter E; Affranchino JL; González SA J Virol; 2003 Oct; 77(20):10881-8. PubMed ID: 14512538 [TBL] [Abstract][Full Text] [Related]
19. Genetic evidence for an interaction between human immunodeficiency virus type 1 matrix and alpha-helix 2 of the gp41 cytoplasmic tail. Murakami T; Freed EO J Virol; 2000 Apr; 74(8):3548-54. PubMed ID: 10729129 [TBL] [Abstract][Full Text] [Related]
20. Assembly of the matrix protein of simian immunodeficiency virus into virus-like particles. González SA; Affranchino JL; Gelderblom HR; Burny A Virology; 1993 Jun; 194(2):548-56. PubMed ID: 8503172 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]